Sun Pharmaceutical Industries, announced its release of Leqselvi in the U.S. earlier this week. Leqselvi™ is currently ...

MUMBAI: India’s equity benchmarks snapped a four-session losing streak on Tuesday, as lower-than-expected domestic inflation ...

The stigma of having alopecia causes more depression and anxiety than the disease itself, new research has found.

Equity benchmarks ended a four-day losing streak with modest gains on Tuesday, as easing CPI inflation lifted investor sentiment. Hopes of a potential rate cut spurred buying interest, pushing all NSE ...

Foreign investors turned net buyers in Indian equities on Tuesday after heavy selling a day prior, while domestic ...

Sun Pharma shares surged after a settlement with Incyte over Leqselvi, a drug for severe hair loss. The agreement includes a ...

Shares of Sun Pharmaceutical Industries climbed nearly 3 per cent on Tuesday after the firm said it has inked a settlement pact with US-based Incyte Corporation regarding Leqselvi, a drug used for ...

India's equity indices ended a four-session decline, as inflation data came in lower than anticipated, increasing hopes for ...

Indian stock markets saw a recovery on Tuesday. Sensex and Nifty closed higher after a four-day losing streak. Market ...

Indian drugmaker Sun Pharmaceutical Industries together with its subsidiaries announced that further to its intimation dated ...

Going forward, Aadhaar-based OTP verification has been made compulsory for Tatkal ticket bookings on IRCTC. This requirement ...

LEQSELVI has been approved by the US FDA, following strong results from clinical trials and is now available to adults ...